Page 1 of Clinical Trials for Drug Glatiramer acetate with placebo, 27 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
Last Updated: April 11, 2011
Condition(s): Relapse Remitting Multiple Sclerosis
2
Completed
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.
Last Updated: April 7, 2011
Condition(s): Multiple Sclerosis
3
Active, not recruiting
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
Last Updated: April 18, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis
4
Completed
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
Last Updated: August 22, 2011
Condition(s): Optic Neuritis
5
Recruiting
Efficacy and Safety of GTR in Comparison to Copaxone®
Last Updated: April 20, 2012
Condition(s): Multiple Sclerosis
6
Recruiting
A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease
Last Updated: March 1, 2009
Condition(s): Crohns Disease
7
Completed
Study to Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to CDMS of Subjects Presenting With CIS
Last Updated: April 4, 2011
Condition(s): Multiple Sclerosis
8
Recruiting
To Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With RRMS
Last Updated: May 17, 2012
Condition(s): Relapsing-Remitting Multiple Sclerosis
9
Active, not recruiting
A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo
Last Updated: April 10, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis
10
Completed
Treatment Interruption of Natalizumab
Last Updated: January 12, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis
11
Completed
Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis
Last Updated: June 17, 2009
Condition(s): Multiple Sclerosis, Relapsing-Remitting
12
Completed
Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
Last Updated: May 11, 2012
Condition(s): Amyotrophic Lateral Sclerosis
13
Completed
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
Last Updated: January 9, 2012
Condition(s): Multiple Sclerosis
14
Completed
Pilot Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
Last Updated: June 17, 2011
Condition(s): Multiple Sclerosis
15
Withdrawn
The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections
Last Updated: August 2, 2011
Condition(s): Multiple Sclerosis
16
Active, not recruiting
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Last Updated: January 23, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis
17
Recruiting
A Double Blinded, Placebo Controlled, Randomized Study Comparing Rituximab Induction Therapy Followed by Glatiramer Acetate Therapy to Glatiramer Acetate Monotherapy in Patients With Relapsing Forms of Multiple Sclerosis
Last Updated: April 2, 2012
Condition(s): Multiple Sclerosis
18
Completed
Treatment of Multiple Sclerosis With Copaxone and Albuterol
Last Updated: May 7, 2012
Condition(s): Autoimmune Diseases; Multiple Sclerosis
19
Completed
Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
Last Updated: September 29, 2011
Condition(s): Relapsing-remitting Multiple Sclerosis
20
Recruiting
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients With Multiple Sclerosis Taking Glatiramer Acetate
Last Updated: October 18, 2011
Condition(s): Multiple Sclerosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Glatiramer+acetate+with+placebo

Page 1 of Clinical Trials for Drug Glatiramer acetate with placebo, 27 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About